We aim to clarify the complex role of PRMT1 in TNBC, an aggressive and treatment-resistant breast cancer subtype, by exploring its impact on cell proliferation, migration, invasion, chemoresistance, and lung metastasis. The gene discussed is PRMT1; the disease is breast carcinoma.